CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,328,435
- in 8 filings, $4.3M under 10b5-1 plans
Net −$4,328,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- SAYER KEVIN R −$2.4M Executive Chair sold 8% of stake
- AUGUSTINOS NICHOLAS −$680K Director sold 22% of stake
- Stern Sadie −$649K EVP Chief People & Culture Off sold 6% of stake
- Sylvain Jereme M −$303K EVP, Chief Financal Officer sold 2% of stake
- Brown Michael Jon −$288K EVP Chief Legal Compliance Off sold 3% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-09 | Murphy Patrick Michael EVP, Chief Legal Officer | Sale | −1,003 | $398.30 | $399K | 25,732 |
| 2020-09-09 | MOY JEFFREY EVP Operations | Other disposition | −6,967 | 19,684 | ||
| 2020-09-09 | MOY JEFFREY EVP Operations | Other acquisition | +6,967 | 38,364 | ||
| 2020-09-09 | MOY JEFFREY EVP Operations | Returned to the company | −1,003 | $398.30 | $399K | 37,361 |
| 2020-09-09 | MOY JEFFREY EVP Operations | Returned to the company | −2,577 | $398.30 | $1.0M | 34,784 |
| 2020-09-09 | Leach Jacob Steven EVP Chief Technology Officer | Sale | −2,577 | $398.30 | $1.0M | 104,831 |
| 2020-09-09 | Leach Jacob Steven EVP Chief Technology Officer | Sale | −1,283 | $398.30 | $511K | 103,548 |
| 2020-09-09 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −3,297 | $398.30 | $1.3M | 48,214 |
| 2020-09-09 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −1,402 | $398.30 | $558K | 46,812 |
| 2020-09-09 | Balo Andrew K * | Sale | −1,283 | $398.30 | $511K | 44,120 |
| 2020-09-09 | Balo Andrew K * | Sale | −3,297 | $398.30 | $1.3M | 40,823 |
| 2020-09-09 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −5,159 | $391.00 | $2.0M | 54,782 |
| 2020-09-09 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −1,283 | $398.30 | $511K | 53,499 |
| 2020-09-09 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −3,297 | $398.30 | $1.3M | 50,202 |
| 2020-08-24 | Sylvain Jereme M SVP, Finance & CAO | Sale | −600 | $427.41 | $256K | 12,817 |
| 2020-08-24 | Pacelli Steven Robert EVP Strategy and Corporate Dev | Sale | −1,531 | $427.24 | $654K | 72,877 |
| 2020-08-24 | DOUBLEDAY RICHARD EVP Chief Commercial Officer | Sale | −1,530 | $427.22 | $654K | 1,530 |
| 2020-08-24 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −1,826 | $421.46 | $770K | 67,881 |
| 2020-08-24 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −2,493 | $423.18 | $1.1M | 65,388 |
| 2020-08-24 | Abbey Donald EVP Quality and Regulatory Aff | Sale | −1,500 | $423.69 | $636K | 63,888 |
Page 49 of 55 · 1,082 trades